Status:
NOT_YET_RECRUITING
A Prognosis and Predicting Genetic Study of Lung Cancer
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Lung Cancer
Genetic Predisposition to Disease
Eligibility:
All Genders
20+ years
Brief Summary
Lung cancer is a leading cause of cancer mortality among adults worldwide. The incidence rates of lung cancer among never smoking females in some parts of East Asia are among the highest in the world....
Detailed Description
To delineate the genetic etiology underlying NSCLC, this study proposes to employ a family-based linkage analysis, together with rich data generated from NGS, to search for disease susceptibility locu...
Eligibility Criteria
Inclusion
- The patient's family (within third-degree relatives) has at least one diagnosed of primary non-small cell lung cancer.
- The patient was diagnosed of primary non-small cell lung cancer at the age \< 45 years old.
Exclusion
- Patients without the diagnosis of primary non-small cell lung cancer.
- Patients who are combined with other malignancy and ongoing chemotherapy / radiation therapy.
- Patients combined with coagulopathy.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2037
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03234179
Start Date
August 1 2017
End Date
August 1 2037
Last Update
August 1 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.